PEN
Penumbra (PEN)
$
19About Penumbra (PEN)
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Details
Daily high
$203.84
Daily low
$193.50
Price at open
$193.70
52 Week High
$277.34
52 Week Low
$148.00
Market cap
7.9B
Dividend yield
0.00%
Volume
387,667
Avg. volume
342,221
P/E ratio
593.43
Penumbra News
Details
Daily high
$203.84
Daily low
$193.50
Price at open
$193.70
52 Week High
$277.34
52 Week Low
$148.00
Market cap
7.9B
Dividend yield
0.00%
Volume
387,667
Avg. volume
342,221
P/E ratio
593.43